Efficacy of teprotumumab therapy in patients with long-duration thyroid eye disease. Subramanian PS, Cho RI, Kahana A. Curr Opin Ophthalmol 2023;34:487-492.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Subramanian PS, Cho RI, Kahana A. Efficacy of teprotumumab therapy in patients with long-duration thyroid eye disease. Curr Opin Ophthalmol 2023;34:487-492.
PMID: 37610428